This event is part of the series Exploring APEC’s Role in Facilitating Regional Cooperation.

Digital health technologies hold great promise to strengthen health systems in the Asia-Pacific region and provide affordable access for remote and vulnerable populations. But what is the evidence about how digital health initiatives work in practice in low resource settings? What incentive structures and provider skillsets are needed to improve health equity, health service quality, and health system resilience at an affordable cost? What is the role of APEC in promoting these innovations while also addressing concerns about data privacy and security? This colloquium explores these questions with case studies from South and Southeast Asia. Our three expert speakers discuss how APEC members are actively experimenting with “innovative digital health solutions to increase access to, and delivery of, health services,” as highlighted in the Chair's Statement of the 13th APEC High-Level Meeting on Health and the Economy. 

Panelists:

CK Cheruvettolil, Senior Strategy Officer, Digital Health and Artificial Intelligence, Bill & Melinda Gates Foundation

CK Cheruvettolil is a Senior Strategy Officer on the Gates Foundation Artificial Intelligence Taskforce. He leads the deployment of AI solutions in Asia and works closely with governments, public health agencies and health service providers to identify and fund digital technologies that could have impact. CK has been at the Gates Foundation for 12 years in a variety of roles including financing and strategy for global vaccine development and disease surveillance. 
Prior to joining the Gates Foundation, CK spent 8-years as a consultant to the US Centers for Disease Control and Prevention. In this capacity, he played a crucial role in designing the technical framework for the Environmental Public Health Tracking Network.

Kiran Gopal Vaska, Director of the National Health Authority of India

Mr. Kiran Gopal Vaska is an officer of the Indian Administrative Service (IAS) currently working at the National Health Authority, New Delhi. In his earlier roles, he worked at various levels of government in the areas of power, rural development, health and family welfare, education, and industrial development, among others. As Managing Director of MP Eastern Zone Power Distribution Company, he led the digitization of the company including GIS mapping of the entire power network, introduction of smart meter technologies, and more. He led the development of an online single window system and was instrumental in Madhya Pradesh state ranking among the top 5 states in Ease of Doing Business (EoDB) in India for 2016. Before joining government service, he worked in the finance industry performing risk analytics for hedge funds and banks.

Moderator:

​​Dr. Siyan Yi, Assistant Professor and Director of Integrated Research Program at National University of Singapore; 2011-12 Developing Asia Health Policy Fellow, Shorenstein APARC

Dr. Yi is a medical doctor and an infectious disease epidemiologist by training. He received his PhD from the School of International Health of the University of Tokyo in Japan in 2010. He was a postdoctoral fellow at the Asia Health Policy Program, Walter H. Shorenstein Asia Pacific Research Center, Stanford University from 2011-2012. He is an Assistant Professor and Director of the Integrated Research Program at Saw Swee Hock School of Public Health, National University of Singapore. He also serves as Director of KHANA Center for Population Health Research in Cambodia and Adjunct Associate Professor at Touro University California, the United States. His implementation research program focuses on developing and evaluating community-based innovative interventions for improving access to prevention, treatment, and care services for HIV/AIDS, tuberculosis, sexual and reproductive health, and maternal and child health among vulnerable and marginalized populations in Southeast Asia.

For more information about on-campus parking, visit our Contact page.

Co-sponsored by Peking University Institute for Global Health and Development, and the Asia Health Policy Program

Adolescents in Sub-Saharan Africa have some of the highest rates of intimate partner violence across the globe. This paper evaluates the impact of a randomized controlled trial that offers females a goal setting activity to improve their sexual and reproductive health outcomes and offers their male partners a soccer intervention, which educates and inspires young men to make better sexual and reproductive health choices. Both interventions reduce female reports of intimate partner violence. Impacts are larger among females who were already sexually active at baseline. We develop a model to understand the mechanisms at play. The soccer intervention improves male attitudes around violence and risky sexual behaviors. Females in the goal setting arm take more control of their sexual and reproductive health by exiting violent relationships. Both of these mechanisms drive reductions in IPV.

Manisha Shah is the Franklin D. Gilliam, Jr., Endowed Chair in Social Justice and Professor of Public Policy at the UCLA Luskin School of Public Affairs and Founding Director of the Global Lab for Research in Action. She is an affiliate of NBER, CEGA, JPAL, BREAD, and IZA. Her research focuses on development economics, particularly applied microeconomics, health, and development. She has written several papers on the economics of sex markets in order to learn how more effective policies and programs can be deployed to slow the spread of HIV/AIDS and other sexually transmitted infections. She also works in the area of child health and education. . Shah has been the PI on various impact evaluations and randomized controlled trials and is currently leading projects in Tanzania, Indonesia, and India. She has also worked extensively in Ecuador and Mexico. Her research has been supported by Bill and Melinda Gates Foundation, William and Flora Hewlett Foundation, the World Bank, and the National Science Foundation among others. She is an editor at Journal of Health Economics and an Associate Editor at The Review of Economics and Statistics. Shah received her Ph.D. from UC Berkeley.

This event will offer simultaneous translation between Japanese and English. 
当イベントは日本語と英語の同時通訳がついています。

This is a virtual event. Please click here to register and generate a link to the talk. 
The link will be unique to you; please save it and do not share with others.
当イベントはZoomウェビナーで行われます。ウェビナーに参加するためには、こちらのリンクをクリックし、事前登録をして下さい。

Febuary 14, 4-5:30 p.m. California time/ February 15, 9-10:30 a.m. Japan time

This event is part of the 2022 Japan Program Winter webinar series, The Future of Social Tech: U.S.-Japan Partnership in Advancing Technology and Innovation with Social Impact

 

COVID-19 has changed the way we work. While remote work has become the norm, the pandemic has also highlighted the inequity in childcare, elderly care, and household work. Japanese workplaces feel a particularly acute need for adjustment, as lack of digitalization and persistent gender inequality continue to limit productivity gains and diversity in the workforce. Social entrepreneurs in Japan have started offering new technologies that address these problems and transform Japanese work environments, using matching algorithms, innovative apps, and other new technologies. How can these social technologies reshape the workplace? What principles do we need in using these technologies in practice, in order to unlock the keys to untapped human resource potentials and realize a more equitable and inclusive work environment in Japan, the United States, and elsewhere?  Fuhito Kojima, a renowned economist specializing in matching theory, will talk about market design from the perspective of regulation design and economics, and Eiko Nakazawa, an influential entrepreneur, will speak about her experiences founding education and childcare startups in the United States and Japan, moderated by Yasumasa Yamamoto, a leading expert on technology and business in Japan and the United States. 

 

Panelists

Fuhito Kojima is a Professor of Economics at the University of Tokyo and Director of the University of Tokyo Market Design Center. He received a B.A. at University of Tokyo (2003) and PhD at Harvard (2008), both in economics and taught at Yale (2008-2009, as postdoc) and then Stanford (2009-2020, as professor) while spending one year at Columbia in his sabbatical year. His research involves game theory, with a particular focus on “market design,” a field where game-theoretic analysis is applied to study the design of various mechanisms and institutions. His recent works include matching mechanism designs with complex constraints, and he is working on improving medical residency match and daycare seat allocation in Japan based on his academic work. Outside of academia, he serves as an advisor for Keizai Doyu Kai as well as several private companies.

 

Eiko Nakazawa is the Founder and CEO of Dearest, Inc., a VC-Backed startup in the United States that makes high-quality learning, childcare, and parenting support accessible by helping employers subsidize those costs for their working families. She also advises and invests in early-stage startups, and has recently co-founded Ikura, Inc., an education x fintech company in Japan. Prior to founding Dearest, Nakazawa spent 11 years with Sony Corporation, where she led global marketing, turnaround, and new business launch initiatives. Nakazawa earned an M.S. in Management from Stanford Graduate School of Business.

 

 

Moderator

Yasumasa Yamamoto is a Visiting Professor at Kyoto University graduate school of management and has been a specialist in emerging technology such as fintech, blockchain, and deep learning. He was previously industry analyst at Google, senior specialist in quantitative analysis of secularized products, as well as derivatives at Bank of Tokyo Mitsubishi in New York. Yamamoto holds a M.S. from Harvard University and a masters degree from University of Tokyo.

 

This event will offer simultaneous translation between Japanese and English. 
当イベントは日本語と英語の同時通訳がついています。

This is a virtual event. Please click here to register and generate a link to the talk. 
The link will be unique to you; please save it and do not share with others.
当イベントはZoomウェビナーで行われます。ウェビナーに参加するためには、こちらのリンクをクリックし、事前登録をして下さい。

February 7, 5-6:30 p.m. California time/ February 8, 10-11:30 a.m. Japan time

This event is part of the 2022 Japan Program Winter webinar series, The Future of Social Tech: U.S.-Japan Partnership in Advancing Technology and Innovation with Social Impact

Japan’s startup scene has become more exciting in recent years, but in the medical field, the failure to develop COVID-19 vaccines highlighted the shortcomings of Japan’s medical industry. What should Japan do to foster more impactful biotechnology entrepreneurship that would leverage vibrant medical research carried out at Japanese universities? The panel features two speakers who founded and grew their medical ventures in Japan's rapidly maturing startup ecosystem, both with deep connections to university research. 

Tadahisa Kagimoto founded his first company right after finishing his medical degree at Kyushu University, pioneering a pathway of commercializing biotechnology from Japanese university research. His second startup, Healios, founded in 2013 with the goal of becoming a pioneer in regenerative medicine utilizing iPS, was successfully listed on the Tokyo Stock Exchange in 2015 and has been growing since.

Shoko Takahashi was a PhD student in molecular bioscience at the University of Tokyo when she founded her company, Genequest, to offer home DNA testing. The firm was purchased by another biotech startup founded by a University of Tokyo graduate, Euglena, in 2017, and the company has partnered with a variety of pharmaceutical, food and beverage companies, and universities in its research. Their entrepreneurial journeys reveal Japan's changing startup ecosystem that has rapidly matured over the past decade and signal a need for further development in regulatory environments, human resource development, and university-industry collaboration in the biotechnology industry.

 

Panelists

Hardy TS Kagimoto, MD is founder, Chairman and CEO of HEALIOS K.K., a Tokyo-based, clinical-stage world leader in regenerative medicine and cell therapy. 

After founding Healios in 2011, Dr. Kagimoto led the company’s listing on the Tokyo Stock Exchange in 2015 and has built the company to its current scale of more than 140 people across its Japan and US offices. Healios leverages the favorable Japanese regulatory framework for regenerative medicine to efficiently deliver results for patients and its stakeholders. It is currently running two pivotal clinical trials for ischemic stroke and acute respiratory distress syndrome using bone marrow-derived allogeneic multipotent adult progenitor cells. At the same time, Healios is developing best-in-class, next generation pipeline assets in immuno-oncology, ophthalmology, and organ buds utilizing its innovative, proprietary universal donor iPS cell platform.

 

Shoko Takahashi founded the Japanese personal genome company Genequest Inc. in 2013 while a graduate student at the University of Tokyo. Genequest provides a web-based personal genetic service for consumers and collaborates with research institutions in a large-scale genome research project to maximize synergistic effects between research and personal genome services. She is filled with ambition to accelerate genetic research and contribute to human health all over the world. She graduated from the University of Tokyo with a Ph.D. in Molecular Bioscience in 2015, and Kyoto University with a Bachelor of Biochemistry Science in 2010. She has been awarded the Japan Venture Award and received the highest rating by the Japan Ministry of Economy. In 2015, she was commended by the Japan Minister of Education, Culture, Sports, Science and Technology as one of the researchers contributing major innovations to science technologies in Japan.

She received the 2018 Young Global Leaders award from the World Economic Forum and was selected for Newsweek's ‘100 respected Japanese in the world’ list.

 

Moderator

Kenji E. Kushida is a Senior Fellow, Carnegie Endowment for International Peace. He previously was with the Japan Program at the Walter H. Shorenstein Asia-Pacific Research Center as a research scholar.

Kushida’s research and projects focused on the following streams : 1) how politics and regulations shape the development and diffusion of Information Technology such as AI; 2) institutional underpinnings of the Silicon Valley ecosystem, 2) Japan's transforming political economy, 3) Japan's startup ecosystem, 4) the role of foreign multinational firms in Japan, 4) Japan's Fukushima nuclear disaster. He spearheaded the Silicon Valley - New Japan project that brought together large Japanese firms and the Silicon Valley ecosystem.

He has published several books and numerous articles in each of these streams, including “The Politics of Commoditization in Global ICT Industries,” “Japan’s Startup Ecosystem,” "How Politics and Market Dynamics Trapped Innovations in Japan’s Domestic 'Galapagos' Telecommunications Sector," “Cloud Computing: From Scarcity to Abundance,” and others. His latest business book in Japanese is “The Algorithmic Revolution’s Disruption: a Silicon Valley Vantage on IoT, Fintech, Cloud, and AI” (Asahi Shimbun Shuppan 2016).